← Evidence map

ArticleTrials2026

ORIGIN-1 trial: study protocol for an organoid-guided N-of-1 trial evaluating CFTR modulator response in cystic fibrosis with rare non-F508del mutations.

Lorena Rodrigues Sabino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

ORIGIN-1 trial: study protocol for an organoid-guided N-of-1 trial evaluating CFTR modulator response in cystic fibrosis with rare non-F508del mutations. | OpenQuestion